Burning Rock Biotech Ltd (BNR)
3.76
+0.26
(+7.43%)
USD |
NASDAQ |
Nov 14, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Burning Rock Biotech Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.0017 |
| March 31, 2022 | 0.0014 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0013 |
| September 30, 2021 | 0.0036 |
| June 30, 2021 | 0.0172 |
| March 31, 2021 | 0.0172 |
| December 31, 2020 | 0.0174 |
| September 30, 2020 | 0.0156 |
| June 30, 2020 | 0.0181 |
| March 31, 2020 | 0.0689 |
| December 31, 2019 | -0.0648 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.0648
Minimum
Dec 2019
0.0689
Maximum
Mar 2020
0.0051
Average
0.0013
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 2.047 |
| Zai Lab Ltd | 0.0998 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 140.80M |
| Total Liabilities (Quarterly) | 47.54M |
| Shareholders Equity (Quarterly) | 93.26M |
| Current Ratio | 3.105 |